Verena Hug

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

Gabriel N. Hortobágyi, D. Frye, Aman U. Buzdar et al. · Cancer · 1989 · 199 citations · Full text

Phase II Evaluation of Lyl56758 in Metastatic Breast Cancer

Aman U. Buzdar, Connie Marcus, Frankie A. Holmes et al. · Oncology · 1988 · 176 citations

Phase Ii Evaluation, Breast Oncology, Medicine +11

Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.

Verena Hug, Gabriel N. Hortobágyi, Benjamin Drewinko et al. · Journal of Clinical Oncology · 1985 · 83 citations

Tumor Biology, Breast Oncology, Medicine +13

Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count

Verena Hug, Michael J. Keating, K. B. McCredie et al. · Cancer · 1983 · 79 citations · Full text

Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.

William Plunkett, Verena Hug, Michael J. Keating et al. · PubMed · 1980 · 73 citations

1-Beta-d-arabinofuranosylcytosine Therapy, Mixed-phenotype Acute Leukemia, Immunology +16